Automated Multiplex CRISPR-Cas12n (CasNano) Vector Foundry Cap Rate 2026

Underwrite GMP Class A/B continuous synthetic sub-350 amino acid ultra-compact Cas12n (CasNano) non-viral synthetic lipid nanoparticle (LNP) packaging cleanroom suites, $605/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

CasNano Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP CasNano Foundry Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation